Monogenic Diabetes Center

Monogenic Diabetes Center at Texas Children’s Hospital and Baylor College of Medicine

At the Monogenic Diabetes Center at Texas Children’s Hospital and Baylor College of Medicine, cutting-edge medical care meets compassionate expertise for children suspected to have or diagnosed with monogenic diabetes. We achieve our mission of ensuring optimal medical care for these children through a multifaceted approach:

  • Comprehensive Evaluation: We specialize in thorough clinical and genetic assessments to improve the identification of monogenic diabetes cases.
  • Tailored Treatment: Depending on the specific type of monogenic diabetes diagnosed, we offer personalized treatment options aimed at optimizing health outcomes.
  • Continual Support: Our team provides continuous care and follow-up throughout childhood, addressing any issues that may arise in the natural course of the disease.
  • Pioneering Research: Leveraging our extensive clinical and genetic databases, we actively contribute to the discovery of new insights and advancements in the field of monogenic diabetes.
  • Research-Based Testing: For individuals whose clinical evaluation does not yield definitive answers, we offer research-based testing options as available to further elucidate their condition.
  • Collaborative Efforts: We collaborate with national and international institutions to advance research efforts and enhance understanding of monogenic diabetes.

Our center is proud to offer specialized care for monogenic diabetes in Texas. Our national distinctions contribute to our ability to provide optimal diagnostic and medical care for individuals with monogenic diabetes. They include:

  • We benefit from a diverse patient population within the Houston metropolitan area.
  • Our close collaboration with the Department of Genetics, a nationally renowned department at Texas Children’s Hospital and Baylor College of Medicine enhances our diagnostic capabilities and treatment approaches. 
  • Our strong national and international collaborations in monogenic diabetes and atypical diabetes enable us to offer unparalleled medical care to a unique population. 

What is Monogenic Diabetes?

Monogenic diabetes encompasses a spectrum of disorders triggered by a single genetic mutation, including maturity-onset diabetes of the young (MODY) and neonatal diabetes, among others. This form of diabetes serves as a beacon of precision medicine within the diabetes field. Precise diagnosis of specific monogenic diabetes types enables healthcare providers to tailor treatment plans, offering alternatives such as oral medications in place of intensive insulin regimens. 

Additionally, accurate diagnosis empowers us to provide essential medical guidance regarding the risk of diabetes in at-risk family members. With the advent of genomic medicine initiatives, we anticipate both an expansion in the number of identified monogenic diabetes cases and an augmentation of management options in the years to come.
We offer a wide range of services tailored to individuals suspected of having monogenic diabetes, including thorough clinical and genetic evaluations. Our expertise extends to the diagnosis and treatment of various forms of monogenic diabetes, such as maturity-onset diabetes of the young (MODY), neonatal diabetes, and others. Additionally, we provide ongoing medical care and support for individuals who have already received a diagnosis of monogenic diabetes.